Latest National Eye Institute Stories
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2).
Los Angeles Latino eye study is first to track eye disease incidence in Latino population.
Ranibizumab injections plus laser therapy results in dramatic visual improvement.
NEW YORK, April 12 /PRNewswire/ -- Scientists have shown that through eye exams at the crib-side, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children. See video from National Eye Institute at: http://inr.mediaseed.tv/NEI_37353 ROP is one of the most common causes of vision loss in children and affects an estimated 15,000 premature infants...
A large genetic study of age-related macular degeneration (AMD) has identified three new genes associated with this blinding eye diseaseâ€”two involved in the cholesterol pathway.
Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children.
There are far more Americans diagnosed with nearsightedness than just three decades ago.
An international team, led by researchers from the University of California, San Diego School of Medicine and the National Eye Institute, has discovered gene variants for glaucoma in a black population.
Scientists have identified the first long-term, effective treatment to improve vision and reduce vision loss associated with blockage of large veins in the eye.